- Home
- KNSA vs WING Comparison
KNSA vs WING Comparison
Compare KNSA & WING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | WING |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.4B |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | KNSA | WING |
|---|---|---|
| Price | $79.55 | $120.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 28 |
| Target Price | $98.00 | ★ $196.08 |
| AVG Volume (30 Days) | 408.7K | ★ 1.3M |
| Earning Date | 10-27-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | ★ 225.00 | 67.84 |
| EPS | 0.27 | ★ 2.23 |
| Revenue | $677,564,000.00 | ★ $696,853,000.00 |
| Revenue This Year | $46.66 | $9.72 |
| Revenue Next Year | $22.90 | $15.86 |
| P/E Ratio | $291.67 | ★ $53.14 |
| Revenue Growth | ★ 60.09 | 11.35 |
| 52 Week Low | $35.53 | $95.82 |
| 52 Week High | $82.94 | $302.80 |
Technical Indicators
Market Signals| Indicator | KNSA | WING |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 63.18 |
| Support Level | $73.81 | $116.35 |
| Resistance Level | $81.42 | $126.24 |
| Average True Range (ATR) | 2.60 | 4.82 |
| MACD | 0.30 | 2.60 |
| Stochastic Oscillator | 86.28 | 97.17 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About WING Wingstop Inc.
Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.